Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Clin Cardiol ; 41(12): 1611-1616, 2018 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-30350436

RESUMEN

BACKGROUND: Lyme carditis (LC), an early manifestation of Lyme disease that most commonly presents as high-degree atrioventricular block (AVB), usually resolves with antibiotic treatment. When LC is not identified as the cause of AVB, a permanent pacemaker may be inappropriately implanted in a reversible cardiac conduction disorder. HYPOTHESIS: The likelihood that a patient's high-degree AVB is caused by LC can be evaluated by clinical characteristics incorporated into a risk stratification tool. METHODS: A systematic review of all published cases of LC with high-degree AVB, and five cases from the authors' experience, was conducted. The results informed the development of a new risk stratification tool, the Suspicious Index in LC (SILC) score. The SILC score was then applied to each case included in the review. RESULTS: Of the 88 cases included, 51 (58%) were high-risk, 31 (35.2%) intermediate-risk, and 6 (6.8%) low-risk for LC according to the SILC score (sensitivity 93.2%). For the subset of 32 cases that reported on all SILC variables, 24 (75%) cases were classified as high-risk, 8 (25%) intermediate-risk, and 0 low-risk (sensitivity 100%). Specificity could not be assessed (no control group). Notably, 6 of the 11 patients who received permanent pacemakers had reversal of AVB with antibiotic treatment. CONCLUSION: The SILC risk score and COSTAR mnemonic (constitutional symptoms; outdoor activity; sex = male; tick bite; age < 50; rash = erythema migrans) may help to identify LC in patients presenting with high-degree AVB, and ultimately, minimize the implantation of unnecessary permanent pacemakers.


Asunto(s)
Bloqueo Atrioventricular/etiología , Manejo de la Enfermedad , Electrocardiografía , Enfermedad de Lyme/complicaciones , Miocarditis/complicaciones , Antibacterianos/uso terapéutico , Bloqueo Atrioventricular/diagnóstico , Humanos , Enfermedad de Lyme/diagnóstico , Enfermedad de Lyme/tratamiento farmacológico , Miocarditis/diagnóstico , Miocarditis/tratamiento farmacológico
2.
Am J Cardiol ; 121(9): 1102-1104, 2018 05 01.
Artículo en Inglés | MEDLINE | ID: mdl-29598856

RESUMEN

Canada has seen a sixfold increase in Lyme disease since being nationally notifiable in 2009. This is the first Canadian series on Lyme carditis manifested as high-degree atrioventricular block. We report 5 recent cases presented over a 2-year period. The variation of nonspecific presentations requires a high index of suspicion for prompt diagnosis and correct management. Recognizing this early would curtail the progression of conduction disorders and potentially avoid permanent pacemaker implantation.


Asunto(s)
Bloqueo Atrioventricular/fisiopatología , Enfermedad de Lyme/fisiopatología , Miocarditis/fisiopatología , Adolescente , Adulto , Antibacterianos/uso terapéutico , Bloqueo Atrioventricular/diagnóstico , Bloqueo Atrioventricular/tratamiento farmacológico , Canadá , Ceftriaxona/uso terapéutico , Doxiciclina/uso terapéutico , Ecocardiografía , Electrocardiografía , Eritema Crónico Migrans , Prueba de Esfuerzo , Humanos , Enfermedad de Lyme/diagnóstico , Enfermedad de Lyme/tratamiento farmacológico , Masculino , Miocarditis/diagnóstico , Miocarditis/tratamiento farmacológico , Índice de Severidad de la Enfermedad , Mordeduras de Garrapatas , Adulto Joven
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA